Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 08

2280P - MiR-193a-3p: A pan-repressor of H2S synthesizing enzymes regulates tumorigenesis and immunosurveillance in breast cancer

Date

21 Oct 2023

Session

Poster session 08

Topics

Cancer Biology;  Tumour Immunology;  Translational Research;  Targeted Therapy;  Molecular Oncology;  Immunotherapy

Tumour Site

Breast Cancer

Presenters

Alyaa Dawoud

Citation

Annals of Oncology (2023) 34 (suppl_2): S1152-S1189. 10.1016/S0923-7534(23)01927-0

Authors

A. Dawoud1, R.A. Youness2, H.M. Nafea1, C. Bourquin3, C. Szabo4, R.M. Abdel-Kader5, M. Gad1

Author affiliations

  • 1 Biochemistry Department, GUC - German University in Cairo, 11835 - New Cairo/EG
  • 2 Pharmaceutical Biology Department, GUC - German University in Cairo, 11432 - New Cairo/EG
  • 3 Department Of Anaesthesiology, Pharmacology, Intensive Care And Emergency Medicine, UNIGE - Université de Genève - Centre Médical Universitaire (CMU), 1206 - Geneva/CH
  • 4 Pharmacology, University of Fribourg, 1712 - Fribourg/CH
  • 5 Pharmacology & Toxicology Dept., GUC - German University in Cairo, 11432 - New Cairo/EG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2280P

Background

Hydrogen sulfide (H2S) is an endogenous gaseous mediator implicated in breast cancer (BC) progression. The 3 principle enzymes responsible for H2S production in mammals are cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3MST), whose overexpression was correlated with poor prognosis in BC patients. Besides, H2Swas linked to the suppression of tumor immune microenvironment in BC. Our group recently reported that upon single or dual inhibition of any of H2S-synthesizing enzymes, the other untargeted enzyme(s) is/are upregulated/activated as a compensatory mechanism for maintaining the level of H2Sin cancer cells. Thus, the aim of this work is to find a pan-repressor of all 3 enzymes to skip the above compensatory/escape mechanism and to investigate its impact on oncogenic and immunogenic profiles of BC cells.

Methods

BC female patients (n=20) were recruited. In-silico analysis was used to identify microRNAs (miRNAs) that target CBS, CSE, and 3MST. MDA-MB-231 TNBC cells were cultured and transfected by oligonucleotides. Total RNA was extracted using Biazol, reverse transcribed and quantified using qRT-PCR. Western blot analysis was performed. H2S levels were measured by AzMc. BC hallmarks were assessed by MTT, transwell migration, and clonogenic assays.

Results

MiRNA-193a was validated to regulate the expression of H2S enzymes by 8 different bioinformatics software, and was found to be significantly downregulated in BC tissues. Further, miR-193a was negatively correlated with CBS, CSE and 3MST levels in BC patients. Ectopic expression of miR-193a resulted in a marked repression of CBS, CSE, and 3MST expression, inducing a significant decrease in cellular H2S production. in TNBC cells overexpressing miRNA-193a, not only the cancer hallmarks were markedly suppressed but also the immune-suppressor proteins Galectin (GAL) 3 and GAL 9 were decreased significantly.

Conclusions

This study identifies miRNA-193a as a pan-repressor of the 3 principle H2S-synthesizing enzymes in BC, bypassing the compensatory behavior observed at single or dual inhibition of H2S enzymes. Thus, miR-193a emerges as a novel tumor suppressor and immunomodulatory miRNA in TNBC.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Swiss National Science Foundation (SNSF) grant SNF IZSTZ0_198887.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.